Flagship Pioneering introduced the latest company, Mirai Bio, during the BioProcess International Conference in Boston.

MED6-189 targets and disrupts the parasite’s apicoplast and also vesicular trafficking pathways, a dual mode of action that ...

NIM Agent Blueprint based on cloud-native "microservices" aim to accelerate virtual screening of small molecules using ...

Sixteen patients dosed with Pfizer’s sickle cell disease drug Oxbryta® (voxelotor) in a pair of clinical trials have died, ...

Scientists from Harvard Medical School are using artificial intelligence (AI) to solve the problem of finding treatments for ...

As Congress wrangles over a budget for the 2025 federal fiscal year, which begins October 1, the NIH will be paying especially close attention. Last year, the NIH saw its first year-over-year funding ...

Researchers suggest the DeepRVAT model is the first to use artificial intelligence (AI) in genomic association studies to decipher rare genetic variants.

The BPI meeting kicked off on Tuesday morning with an opening plenary session led by Sarah Glaven, from the White House OSTP.

While the cell and gene therapy industry has recognized its potential, few companies to date have embraced artificial ...

Showing the power of modeling in gathering valuable information could encourage more people to use these tools for their own ...

Biomedicines’ generative artificial intelligence (AI) platform to discover and develop protein therapeutics for multiple ...

Researchers analyzed datasets to study brain circuitry that might be causally linked to PTSD in military veterans.